Td Asset Management Inc Seres Therapeutics, Inc. Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$6.02 - $11.43 $251,184 - $476,916
-41,725 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$17.66 - $28.92 $104,582 - $171,264
5,922 Added 16.54%
41,725 $859,000
Q4 2020

Feb 16, 2021
BUY
$23.25 - $37.73 $104,625 - $169,785
4,500 Added 14.38%
35,803 $877,000
Q3 2020

Nov 10, 2020
BUY
$3.74 - $28.74 $117,073 - $899,648
31,303 New
31,303 $886,000

Others Institutions Holding MCRB

# of Institutions
82
Shares Held
40.5M
Call Options Held
304K
Put Options Held
471K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $103M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email